{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T11:39:32Z","timestamp":1725795572336},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1994,9,1]],"date-time":"1994-09-01T00:00:00Z","timestamp":778377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[1994,9]]},"DOI":"10.1007\/bf00365578","type":"journal-article","created":{"date-parts":[[2004,11,12]],"date-time":"2004-11-12T16:56:56Z","timestamp":1100278616000},"page":"279-285","source":"Crossref","is-referenced-by-count":10,"title":["Antiemetics in children receiving cancer chemotherapy"],"prefix":"10.1007","volume":"2","author":[{"given":"A. L.","family":"Billett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. E.","family":"Sallan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0304-3940(90)90348-D","volume":"111","author":"JM Barnes","year":"1990","unstructured":"Barnes JM, Barnes NM, Costall B, et al (1990) Identification and distribution of 5-HT3 recognition sites within the human brainstem. Neurosci Lett 111: 80?86","journal-title":"Neurosci Lett"},{"key":"CR2","unstructured":"Barnes NM, Barry JM, Costall B, et al (1987) Antagonism by parachlorophenylaline of cisplatin-induced emesis (abstract). Br J Pharmacol 92 [Suppl]: 649P"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1200\/JCO.1992.10.12.1969","volume":"10","author":"TM Beck","year":"1992","unstructured":"Beck TM, Hesketh PJ, Madajewicz S, et al (1992) Stratified, randomized double-blind comparison of intravenous ondansetron administered as a multiple dose regimen versus two single dose regimens in the prevention of cisplatin-induced nausea and vomiting. J Clin Oncol 10:1969?1975","journal-title":"J Clin Oncol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1200\/JCO.1984.2.6.691","volume":"2","author":"JF Bishop","year":"1984","unstructured":"Bishop JF, Olver IN, Wolf MM (1984) Lorazepam: a randomized double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochloperazine. J Clin Oncol 2:691?695","journal-title":"J Clin Oncol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1200\/JCO.1990.8.6.1063","volume":"8","author":"J Bonneterre","year":"1990","unstructured":"Bonneterre J, Chevallier B, Mek R, et al (1990) A randomized double-blinded comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy. J Clin Oncol 8:1063?1069","journal-title":"J Clin Oncol"},{"key":"CR6","first-page":"381","volume":"67","author":"ED Bruera","year":"1983","unstructured":"Bruera ED, Roca E, Cedaro L, et al (1983) Improved control of chemotherapy-induced emesis by addition of dexamethasone to metoclopramide in patients resistant to metoclopramide. Cancer Treat Rep 67:381?383","journal-title":"Cancer Treat Rep"},{"key":"CR7","first-page":"49","volume":"92","author":"JC Bryson","year":"1991","unstructured":"Bryson JC, Pritchard JF, Shurin S, et al (1991) Efficacy, pharmacokinetics (PK), and safety of ondansetron (OND) in pediatric chemotherapy patient (PTS) (abstract). Proc Am Soc Clin Pharmacol Ther 92:49","journal-title":"Proc Am Soc Clin Pharmacol Ther"},{"key":"CR8","first-page":"152","volume-title":"The pharmacologic basis of therapeutics","author":"R Byck","year":"1975","unstructured":"Byck R (1975) Drugs and the treatment of psychiatric disorders. In: Goodman LS, Gilman A (eds) The pharmacologic basis of therapeutics, 5th edn. Macmillan, New York, pp 152?200","edition":"5th edn."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1200\/JCO.1990.8.9.1531","volume":"8","author":"PA Carden","year":"1990","unstructured":"Carden PA, Mitchell SL, Waters KD, et al (1990) Prevention of cyclophosphamide\/cytarabine-induced emesis with ondansetron in children with leukemia. J Clin Oncol 8:1531?1535","journal-title":"J Clin Oncol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/archinte.1983.00350070063012","volume":"143","author":"PA Cassileth","year":"1983","unstructured":"Cassileth PA, Lusk EJ, Torri S, DiNubile N, Gerson SL (1983) Antiemetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy. Arch Intern Med 143:1347?1349","journal-title":"Arch Intern Med"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/1097-0142(19810401)47:7<1746::AID-CNCR2820470704>3.0.CO;2-4","volume":"47","author":"AE Chang","year":"1981","unstructured":"Chang AE, Shiling DJ, Stillman RC, et al (1981) A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving Adriamycin and cytoxan chemotherapy. Cancer 47:1746?1751","journal-title":"Cancer"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJM199003223221204","volume":"322","author":"LX Cubeddu","year":"1990","unstructured":"Cubeddu LX, Hoffmann IS, Fuenmayor NT, Finn AL (1990) Efficacy of ondansetron (GR38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 322:810?816","journal-title":"N Engl J Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-113-11-834","volume":"113","author":"PHM Mulder De","year":"1990","unstructured":"De Mulder PHM, Seynaeve C, Vermorken JB, et al (1990) Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. Ann Intern Med 113:834?840","journal-title":"Ann Intern Med"},{"key":"CR14","first-page":"61","volume":"199","author":"RL Drapkin","year":"1982","unstructured":"Drapkin RL, Sokol GH, Paladine WJ, et al (1982) The antiemetic effect and dose response of dexamethasone in patients receiving cisplatinum. Proc Am Soc Clin Oncol 199:61","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.5694\/j.1326-5377.1979.tb127271.x","volume":"2","author":"H Ekeret","year":"1979","unstructured":"Ekeret H, Waters KD, Jurk IH, et al (1979) Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol. Med J Aust 2:657?659","journal-title":"Med J Aust"},{"key":"CR16","first-page":"470","volume":"84","author":"LN Gay","year":"1949","unstructured":"Gay LN, Carliner PE (1949) The prevention and treatment of motion sickness. Bull Johns Hopkins Hosp 84:470?487","journal-title":"Bull Johns Hopkins Hosp"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM198110153051601","volume":"305","author":"RJ Gralla","year":"1981","unstructured":"Gralla RJ, Itri LM, Piswko SE, et al (1981) Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy induced nausea and vomiting. N Engl J Med 305:905?909","journal-title":"N Engl J Med"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1200\/JCO.1991.9.5.721","volume":"9","author":"J Hainsworth","year":"1991","unstructured":"Hainsworth J, Harvey W, Pendergrass K, et al (1991) A single-blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high-dose cisplatin chemotherapy. J Clin Oncol 9:721?728","journal-title":"J Clin Oncol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1476-5381.1989.tb11948.x","volume":"97","author":"GA Higgins","year":"1989","unstructured":"Higgins GA, Kilpatrick GJ, Bunce KT, et al (1989) 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br J Pharmacol 97:247?255","journal-title":"Br J Pharmacol"},{"key":"CR20","first-page":"245","volume-title":"The pharmacologic basis of therapeutics","author":"JH Jaffe","year":"1975","unstructured":"Jaffe JH, Martin WR (1975) Narcotic analgesics and antagonists. In: Goodman LS, Gilman A (eds) The pharmacologic basis of therapeutics, 5th edn. Macmillan, New York, pp 245?283","edition":"5th edn."},{"key":"CR21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0277-5379(90)90227-K","volume":"26","author":"S Kaasa","year":"1990","unstructured":"Kaasa S, Kvaloy S, Dicato MA, et al (1990) A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: a randomized, double-blinded study. Eur J Cancer 26:311?314","journal-title":"Eur J Cancer"},{"key":"CR22","first-page":"78","volume":"199","author":"AB Khan","year":"1983","unstructured":"Khan AB, Bucklew CA, Leventhal BG (1983) Effectiveness of Decadron and Thorazine in prevention of nausea and vomiting induced by chemotherapy in pediatric patients. Proc Am Soc Clin Oncol 199:78","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR23","first-page":"1257","volume":"69","author":"MG Kris","year":"1985","unstructured":"Kris MG, Gralla RJ, Clark RA, et al (1985) Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone. Improved subjective effectiveness over the combination of diphenhydramine plus metoclopromide plus dexamethasone. Cancer Treat Rep 69:1257?1262","journal-title":"Cancer Treat Rep"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM199003223221205","volume":"322","author":"M Marty","year":"1990","unstructured":"Marty M, Pouillart P, Scholl S, et al (1990) Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. N Engl J Med 322:816?821","journal-title":"N Engl J Med"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1200\/JCO.1987.5.12.1994","volume":"5","author":"BR Meyer","year":"1987","unstructured":"Meyer BR, O'Mara V, Reidenberg M (1987) A controlled clinical trial of the addition of transdermal scopolamine to a standard metoclopramide and dexamethasone antiemetic regimen. J Clin Oncol 5:1994?1997","journal-title":"J Clin Oncol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1126\/science.111.2882.312-c","volume":"111","author":"M Nickerson","year":"1950","unstructured":"Nickerson M (1950) Dramamine. Science 111:312?313","journal-title":"Science"},{"key":"CR27","unstructured":"Palmer R, et al (1994) Efficacy and safety of granisetron in two special patient populations. Semin Oncol (in press)"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/adc.65.8.822","volume":"65","author":"CR Pinkerton","year":"1990","unstructured":"Pinkerton CR, Williams D, Wootton C, et al (1990) 5-HT3 antagonist ondansetron ? an effective outpatient antiemetic in cancer treatment. Arch Dis Child 65:822?825","journal-title":"Arch Dis Child"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1200\/JCO.1991.9.4.675","volume":"9","author":"F Roila","year":"1991","unstructured":"Roila F, Tonato M, Cognetti F, et al (1991) Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone. J Clin Oncol 9:675?678","journal-title":"J Clin Oncol"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJM197510162931603","volume":"293","author":"SE Sallan","year":"1975","unstructured":"Sallan SE, Zinberg NE, Frei E III (1975) Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med 293:795?797","journal-title":"N Engl J Med"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJM198001173020302","volume":"302","author":"SE Sallan","year":"1980","unstructured":"Sallan SE, Cronin CM, Zelen M, et al (1980) Antiemetics in patients receiving chemotherapy for cancer. N Engl J Med 302:134?138","journal-title":"N Engl J Med"},{"key":"CR32","first-page":"302","volume":"18","author":"J Sawicka","year":"1977","unstructured":"Sawicka J, Sallan SE (1977) Transdermal therapeutic system scopolamine: prevention of vomiting associated with cancer chemotherapy (abstract). Proc Am Soc Clin Oncol 18:302","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/bjc.1990.62","volume":"61","author":"DB Smith","year":"1990","unstructured":"Smith DB, Newlands ES, Spruyt OW, et al (1990) Ondansetron (GR38032F) plus dexamethasone: effective antiemetic prophylaxis for patients receiving cytotoxic chemotherapy. Br J Cancer 61:323?324","journal-title":"Br J Cancer"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1001\/jama.1982.03320440031028","volume":"247","author":"SB Strum","year":"1982","unstructured":"Strum SB, McDermed JE, Opfell RW, et al (1982) Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy. JAMA 247:2683?2686","journal-title":"JAMA"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/bmj.2.6199.1188","volume":"2","author":"IL Swann","year":"1979","unstructured":"Swann IL, Thompson EN, Querishi K (1979) Domperidone or metoclopramide in preventing chemotherapeutically induced nausea and vomiting. Br Med J 2:1188?1189","journal-title":"Br Med J"},{"key":"CR36","first-page":"255","volume-title":"Physiological pharmacology, vol 2","author":"SC Wang","year":"1965","unstructured":"Wang SC (1965) Emetic and antiemetic drugs. In: Root WS, Hofmann FE (eds) Physiological pharmacology, vol 2. Academic Press, New York, pp 255?328"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0016-5085(19)36357-7","volume":"22","author":"SC Wang","year":"1952","unstructured":"Wang SC, Borison HL (1952) A new concept of organization of the central emetic mechanism: recent studies on the sites of action of apomorphine, copper sulfate, and cardiac glycosides. Gastroenterology 22:1?12","journal-title":"Gastroenterology"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.1984.2.6.683","volume":"2","author":"L Zelter","year":"1984","unstructured":"Zelter L, LeBaron S, Zelter PM (1984) The effectiveness of behavioral intervention for reduction of nausea and vomiting in children and adolescents receiving chemotherapy. J Clin Oncol 2:683?690","journal-title":"J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00365578.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00365578\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00365578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T01:19:11Z","timestamp":1585963151000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00365578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,9]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1994,9]]}},"alternative-id":["BF00365578"],"URL":"https:\/\/doi.org\/10.1007\/bf00365578","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,9]]}}}